Search

Displaying results 6301 - 6310 of 8469 in total
  1. Drug

    Matsupexole

    go.drugbank.com/drugs/DB21715
    Experimental

    Matsupexole has a monoisotopic molecular weight of 446.25 Da.

  2. Drug

    Balinatunfib

    go.drugbank.com/drugs/DB21728
    Investigational

    Balinatunfib has a monoisotopic molecular weight of 502.19 Da.

  3. Drug

    Rogocekib

    go.drugbank.com/drugs/DB21739
    Investigational

    Rogocekib has a monoisotopic molecular weight of 408.15 Da.

  4. Drug

    Inbakicept

    go.drugbank.com/drugs/DB16479
    Investigational

    [L50592] This combination product was approved by the FDA on April 22, 2024, for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without

  5. Drug

    CoviGlobulin

    go.drugbank.com/drugs/DB15747
    Experimental

    CoviGlobulin, a rabbit polyclonal antibody, was specifically designed as a potential therapy for COVID-19.

  6. Drug

    Sirukumab

    go.drugbank.com/drugs/DB11803
    Investigational

    Sirukumab has been used in trials studying the treatment and basic science of Giant Cell Arteritis and Arthritis, Rheumatoid.

  7. Drug

    AZD-5672

    go.drugbank.com/drugs/DB11804
    Investigational

    Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis.

  8. Drug

    Dalotuzumab

    go.drugbank.com/drugs/DB11840
    Investigational

    Dalotuzumab has been investigated for the treatment of Breast Cancer, Non Small Cell Lung Cancer, and Metastatic Colorectal Cancer.

  9. Drug

    LP-2307

    go.drugbank.com/drugs/DB17470
    Experimental

    It was investigated for melanoma.

  10. Drug

    Tributyrin

    go.drugbank.com/drugs/DB12709
    Investigational

    Tributyrin has been used in trials studying the treatment of Prostate Cancer and Unspecified Adult Solid Tumor, Protocol Specific.